Truncated pardaxin derivative D18.13 induces selective breast cancer apoptosis via predicted targeting of MAPK8.

Cancer remains a global health issue, whereby the adverse effects of conventional drugs urge the discovery of modalities for replacement, such as anticancer peptides with higher selectivity against cancer cells. Bioactive peptide pardaxin has antican…

Preview only. Read the full abstract at the source